To assess the role of these enzymes in the methylation of CAT promoter in leukemia cells, first we characterized DNMT1, DNMT3A, TET1-3 mRNA expression levels in CLL and HD B cells (Fig. 6A). This evidence concerns the gene CAT and leukemia.